India Pesticides Q4 FY26 Results: Net Profit ₹30.6 Cr, Up 40.4% YoY
India Pesticides Ltd reported revenue from operations of ₹266.5 Cr (+28.6% YoY) and net profit of ₹30.6 Cr (+40.4% YoY) for Q4 FY26.
- Key figure
- Net profit ₹30.6 Cr · +40.4% YoY
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
36 announcements with these filters
India Pesticides Ltd reported revenue from operations of ₹266.5 Cr (+28.6% YoY) and net profit of ₹30.6 Cr (+40.4% YoY) for Q4 FY26.
India Pesticides Ltd reported audited FY26 results and recommended a ₹0.75 per share dividend. The board also re-appointed internal, cost, and statutory auditors for the next year.
India Pesticides Limited has scheduled a board meeting on May 23, 2026. The board will consider and approve audited standalone and consolidated financial results for the year ended March 31, 2026, and recommend a final dividend. The trading window remains closed until May 26, 2026.
India Pesticides Limited has scheduled a Board Meeting for May 23, 2026. The board will consider audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and recommend a final dividend. The trading window remains closed until 48 hours after the meeting conclusion.
India Pesticides Limited submitted a clarification to the stock exchanges regarding its XBRL filing for financial results dated November 11, 2025. The company corrected an unintentional error where half-yearly figures were erroneously used instead of quarterly figures during a reporting transition. Revised XBRL filings with appropriate quarterly figures have been submitted.
India Pesticides Limited submitted its quarterly certificate under Regulation 74(5) of SEBI (DP) Regulations for the period ended March 31, 2026. The certificate, issued by KFin Technologies, confirms compliance regarding the dematerialisation and rematerialisation of securities. This is a routine regulatory disclosure with no direct impact on financial performance.